What is the difference between a biotechnology company and a pharmaceutical company?
While biotechnology and pharmaceutical companies both produce medicine, biotechnology companies’ medicines have a biological basis, and pharmaceutical companies’ medicines have a chemical basis. Biotechnology companies use live organisms or their products, such as bacteria or enzymes, to manufacture their drugs. Conversely, pharmaceutical companies use only chemical – and generally artificial – materials to create drugs.
Biotechnology also has more applications than pharmaceutical companies. For example, biotechnology companies have developed versions of crops without specific food allergens, crops that require fewer pesticides and crops with a more complete nutrient profile. While there is some overlap between biotechnology and pharmaceutical companies in terms of research, manufacturing and distributing drugs, biotechnology’s scope is much greater.
There is also a substantial difference in operating costs. especially the cost of research and development. Biotechnology companies have much higher costs due to their focus on research and development (as opposed to manufacturing with pharmaceutical companies) and the length of time and difficulty in testing and creating new products.
The discrepancy in the cost and length of time required to manufacture a new product has led to biotechnology products holding their patents for much longer than pharmaceutical companies. Where pharmaceutical companies generally hold the exclusive rights to manufacture and distribute their drugs for five years, biotechnology companies have their patents for 12 years.
All of this leads to very volatile profits for biotechnology companies. Many operate at a loss for many years until a highly profitable substance is manufactured, when their profits can be even greater than pharmaceutical companies. Conversely, pharmaceutical companies’ profits, and therefore their stock prices, tend to fluctuate less.
Find out how the pharmaceutical companies can benefit from advances in biotechnology with both investors and FDA approval. Read Answer >>
Learn why growth investors looking to beat the market gravitate toward the drugs sector, particularly the newer, high-tech. Read Answer >>
Find out which countries are the largest producers of pharmaceutical products in the world and why the United States dominates. Read Answer >>
Identify the major players in the drugs sector, which include many established pharmaceutical companies that have delved. Read Answer >>
Learn which annual average returns the drugs manufacturing sector and its industries can generate for investors based on. Read Answer >>
Learn more about the drug industry and how new drugs are brought to market. Find out about how drug research is financed. Read Answer >>